Related Experiment Video
Updated: Jul 23, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Neutropenia and antibiotics: when, what, how and why?
Jana Dickter1, Cathy Logan2, Randy Taplitz1
1Division of Infectious Diseases, Department of Medicine, City of Hope National Medical Center, Duarte.
Purpose Of Review:
Our aim is to review recent literature on antibiotic use in patients with neutropenia.
Recent Findings:
Prophylactic antibiotics are associated with risks and have limited mortality benefit. While early antibiotic use in febrile neutropenia (FN) is critical, early de-escalation or discontinuation may be safe in many patients.
Summary:
With an increasing understanding of potential risks and benefits of use and improved risk assessment, paradigms of antibiotic use in neutropenic patients are changing.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urinary Tract Infection IV: Nursing Management
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

